Edition:
India

Krystal Biotech Inc (KRYS.OQ)

KRYS.OQ on NASDAQ Stock Exchange Capital Market

10.61USD
8:39pm IST
Change (% chg)

$0.17 (+1.63%)
Prev Close
$10.44
Open
$10.49
Day's High
$10.61
Day's Low
$10.48
Volume
1,700
Avg. Vol
--
52-wk High
$11.98
52-wk Low
$9.20

Chart for

About

Krystal Biotech, Inc. is a gene therapy company. The Company is engaged in developing and commercializing novel treatments for patients suffering from dermatological diseases. The Company has developed a Skin TARgeted Delivery platform, or STAR-D platform, that consists of a patent pending engineered viral vector based on herpes... (more)

Overall

Beta: --
Market Cap(Mil.): $86.32
Shares Outstanding(Mil.): 8.68
Dividend: --
Yield (%): --

Financials

BRIEF-Krystal Biotech reports qtrly loss per share $1.26‍​

* Krystal Biotech reports that KB103 received clearance from RAC review and announces third quarter 2017 financial results

14 Nov 2017

BRIEF-Krystal Biotech says KB103 granted orphan drug designation by FDA

* Krystal Biotech’s KB103 granted orphan drug designation by the FDA to treat patients with dystrophic epidermolysis bullosa

07 Nov 2017

Earnings vs. Estimates